PNP Therapeutics
Birmingham
About PNP Therapeutics
PNP Therapeutics is an early-stage, biopharmaceutical company engaged in the development of a platform technology and proprietary products for the treatment of cancer. At the center of PNP's Therapeutic System is a patented enzyme (E. coli purine nucleoside phosphorylase) that has been shown to work with a variety of well-characterized nucleoside prodrugs generating active metabolites with high levels of anti-tumor activity.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $2.6M
- Last round: Grant (Nov 2019)
- Website: pnptherapeutics.com
- Phone: +1 205-581-2797
Industries & Categories
Biotechnology, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/pnp-therapeutics-115102 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.